MICHAEL A. MARTINO - 01 Jan 2022 Form 4 Insider Report for Ampio Pharmaceuticals, Inc. (AMPE)

Role
INTERIM CHAIRMAN AND CEO, Director
Signature
/s/ Daniel Stokely, Attorney-in-Fact
Issuer symbol
AMPE
Transactions as of
01 Jan 2022
Transactions value $
$0
Form type
4
Filing time
03 Jan 2022, 19:15:48 UTC
Previous filing
24 Nov 2021
Next filing
26 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPE Stock Option (Right to Buy) Award $0 +250K $0.00 250K 01 Jan 2022 Common Stock 250K $0.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest on November 22, 2022.